CA2617492A1 - Adjuvant chemotherapy for anaplastic gliomas - Google Patents

Adjuvant chemotherapy for anaplastic gliomas Download PDF

Info

Publication number
CA2617492A1
CA2617492A1 CA002617492A CA2617492A CA2617492A1 CA 2617492 A1 CA2617492 A1 CA 2617492A1 CA 002617492 A CA002617492 A CA 002617492A CA 2617492 A CA2617492 A CA 2617492A CA 2617492 A1 CA2617492 A1 CA 2617492A1
Authority
CA
Canada
Prior art keywords
glioma
tert
pbn
butylnitrone
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002617492A
Other languages
English (en)
French (fr)
Inventor
Rheal A. Towner
Yashige Kotake
Robert A. Floyd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oklahoma Medical Research Foundation
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2617492A1 publication Critical patent/CA2617492A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002617492A 2005-08-04 2006-07-28 Adjuvant chemotherapy for anaplastic gliomas Abandoned CA2617492A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70572105P 2005-08-04 2005-08-04
US60/705,721 2005-08-04
PCT/US2006/029152 WO2007019065A2 (en) 2005-08-04 2006-07-28 Adjuvant chemotherapy for anaplastic gliomas

Publications (1)

Publication Number Publication Date
CA2617492A1 true CA2617492A1 (en) 2007-02-15

Family

ID=37727837

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002617492A Abandoned CA2617492A1 (en) 2005-08-04 2006-07-28 Adjuvant chemotherapy for anaplastic gliomas

Country Status (6)

Country Link
US (1) US20070032453A1 (enExample)
EP (1) EP1922075A4 (enExample)
JP (1) JP2009503072A (enExample)
AU (1) AU2006278741A1 (enExample)
CA (1) CA2617492A1 (enExample)
WO (1) WO2007019065A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2005106871A (ru) 2002-08-14 2005-10-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) Ингибиторы протеинкиназ и их применение
US7723301B2 (en) * 2007-08-29 2010-05-25 The Board Of Trustees Of The University Of Arkansas Pharmaceutical compositions comprising an anti-teratogenic compound and applications of the same
US8633249B2 (en) 2008-09-02 2014-01-21 Oklahoma Medical Research Foundation Adjuvant chemotherapy for anaplastic gliomas
JP5242651B2 (ja) * 2010-09-24 2013-07-24 株式会社東芝 レポーター遺伝子構築物、アッセイキットおよび検出方法
CA3074102A1 (en) 2017-09-20 2019-03-28 Oklahoma Medical Research Foundation Treatment of drug resistant gliomas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4928835A (en) * 1989-01-31 1990-05-29 Continental Pet Technologies, Inc. Injection molded preform, method of treating same and container formed therefrom
US5766909A (en) * 1992-02-04 1998-06-16 Merck & Co., Inc. DNA encoding inducible nitric oxide synthase
US5569902A (en) * 1995-01-17 1996-10-29 Welch Allyn, Inc. Contact two-dimensional bar code reader having pressure actuated switch
US5942385A (en) * 1996-03-21 1999-08-24 Sugen, Inc. Method for molecular diagnosis of tumor angiogenesis and metastasis
US6479481B1 (en) * 1999-06-04 2002-11-12 Ed. Geistlich Soehne Ag Fur Chemische Industrie Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
EP1267860A1 (en) * 2000-03-30 2003-01-02 Oklahoma Medical Research Foundation Butylnitrone containing compositions for inhibition of cancer development
EP1525003A1 (en) * 2002-06-28 2005-04-27 Pharmacia Corporation Methods and contrast agents useful in quantifying nitric oxide

Also Published As

Publication number Publication date
JP2009503072A (ja) 2009-01-29
EP1922075A2 (en) 2008-05-21
AU2006278741A1 (en) 2007-02-15
US20070032453A1 (en) 2007-02-08
WO2007019065A3 (en) 2007-11-15
EP1922075A4 (en) 2009-10-14
WO2007019065A2 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
US10398659B2 (en) Adjuvant chemotherapy for anaplastic gliomas
Koukourakis Amifostine in clinical oncology: current use and future applications
US20130280210A1 (en) Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase
US20100029683A1 (en) Methods for regulating cell mitosis by inhibiting serine/threonine phosphateses
AU2018335160B2 (en) Treatment of drug resistant gliomas
US20070032453A1 (en) Adjuvant chemotherapy for anaplastic gliomas
US6653351B2 (en) Adjuvant chemotherapy for anaplastic gliomas
Popović et al. Experimental evaluation of the effects of anticancer modulation therapy on MAPK/PI3K/AKT/mTOR/NF-κB signaling with non-toxic drugs
HK40021256A (en) Treatment of drug resistant gliomas
Ataelmannan Radiosensitizing glioblastoma in a rat model using l-buthionine-sr-sulfoximine (BSO)
WO2011056663A1 (en) Method of treating cancer using combination of a bifunctional alkylating agent and dna repair inhibitors

Legal Events

Date Code Title Description
FZDE Discontinued